Recruiting at 2 sites No phase Cough

Clinical trial for Cough

Official title A Non-pharmacological Cough Control Therapy

ClinicalTrials.gov ID: NCT04767074

What this study is testing

What it's testing
The study wants to see if a cough‑control therapy can be done safely and if it helps reduce cough in ILD patients.
Who it's for
Adults with ILD who have had a chronic cough for more than 8 weeks.
What's involved
Participants will try a cough‑control program added to their usual pulmonary rehab, including breathing exercises and education, and will keep a cough diary.
Time commitment
The program lasts several weeks, with regular visits to the clinic and daily home practice of the exercises.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 85

You may be able to join if

  • Individuals will be included if having confirmed diagnosis of any ILD by a physician (as per Canadian Thoracic Society's guideline for evaluating...

You likely can't join if

  • self-reports of moderate or large sputum production
  • effective or suspected exacerbation of the respiratory condition in the past month
  • upper respiratory tract infection in the past month
  • use of angiotensin-converting enzyme inhibitor medication
  • changes in the prescribed medication in the previous month
  • evidence of traction bronchiectasis in the HRCT
See the full eligibility criteria
Who can join
  • Individuals will be included if having confirmed diagnosis of any ILD by a physician (as per Canadian Thoracic Society's guideline for evaluating patients with fibrotic interstitial lung disease) and a chronic cough...
What rules you out
  • self-reports of moderate or large sputum production
  • effective or suspected exacerbation of the respiratory condition in the past month
  • upper respiratory tract infection in the past month
  • use of angiotensin-converting enzyme inhibitor medication
  • changes in the prescribed medication in the previous month
  • evidence of traction bronchiectasis in the HRCT
  • evidence of other medical conditions that prevent performance of an exercise training program
  • unable to read or speak in English / unable to provide informed consent.

The study team makes the final eligibility decision.

Where it is enrolling

  • Hamilton, Ontario, Canada
  • Toronto, Ontario, Canada

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Hamilton, Ontario, Canada; Toronto, Ontario, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.